Abstract
A human fibroblastic cell line transformed by the SV40-T antigen sequence and continuously cultured for 7 months displayed large periodic variations in cell proliferation. This contrasted with other characteristics of this cell line that remained constant: mosaic cell shape, absence of cell contact inhibition, and predominance of a hypodiploid population. Similar fluctuations in proliferative capacity were also found during the long-term growth of a transformed but nonimmortalized human fibroblastic line prior to senescence, and in the established hamster fibroblastic Nil cell line. This growth pattern suggests a recurrent stimulation of growth in these three transformed cell lines. The proliferation pattern from cultured transformed cells may thus be complex and requires further investigation. These variations presumably influence major cell functions. This observation has important implications for the analysis of data from such cell lines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- I-SF:
-
immortalized human skin fibroblasts
- T-SF:
-
transformed human skin fibroblasts
- FBS:
-
fetal bovine serum
References
Au WW, Callaham MF, Workman ML, Huberman E. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate. Cancer Res. 1983;43:5873.
Benoit C, Chambon P.In vivo requirements of the SV40 early promoter region. Nature. 1981;290:304.
Bravard A, Hoffschir F, Sabatier L et al. Early superoxide dismutase alterations during SV40-transformation of human fibroblasts. Int J Cancer. 1992;52:797.
Brondyk WH, Boeckman FA, Fahl WE. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize. Oncogene. 1991;6:1269.
Chikappa G, Borner G, Burlington H et al. Periodic oscillation of blood leukocytes, platelets, and reticulocytes in a patient with chronic myelocytic leukemia. Blood. 1976;47:1023.
Clement-Lacroix P, Friteau L, Damais C. Activation of human dermal fibroblasts by fibroblast growth factors (FGFs) and/or interleukin-1 beta (IL-1 beta). Lymphokine Cytokine Res. 1991;10:111.
Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA. 1991;88:6028.
Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res. 1991;51:4978.
Donahue LM, Stein GH. Coordinate control of growth arrest states in normal human diploid fibroblasts: effect of cloned SV40 tumor antigen genes. Exp Cell Res. 1989;184:297.
Dutrillaux B. Les anomalies chromosomiques dans les tumeurs solides: quelle signification? Médecine/Sciences 1991;7:10.
Gatti RA, Robinson WA, Deinard AS et al. Cyclic leucocytosis in chronic myelogenous leukemia: new perspectives on pathogenesis and therapy. Blood. 1973;41:771.
Girardi AJ, Jensen FC, Koprowski H. SV40-induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol. 1965;65:69.
Hayflick L. The limitedin vitro lifetime of human diploid cell strains. Exp Cell Res. 1964;37:611.
Kennedy BJ. Cyclic leucocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy. Blood. 1970;35:4751.
Lemonnier F, Gautier M, Wolfrom C, Lemonnier A. Some metabolic differences between human skin and aponeurosis fibroblasts in culture. J Cell Physiol. 1980;104:415.
Levi F, Halberg F. Circaceptan (about-7-day) bioperiodicity —spontaneous and reactive — and the search for pacemakers. Ric Clin Lab. 1982;12:323.
Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453.
McCord JM, Fridovitch I. Superoxide dismutase, an enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049.
Moorhead PS, Saksela E. Non-random chromosomal aberrations in SV40-transformed human cells. J Cell Comp Physiol. 1963;62:57.
Smith JR, Hayflick L. Variation in the life-span of clones derived from human diploid cell strains. J Cell Biol. 1974;62:48.
Smith JR, Whitney RG. Heterogeneity in proliferative potential appears rapidly within a single clone of human diploid fibroblasts. Science 1980;207:82.
Tlsty TD, White A, Sanchez J. Suppression of gene amplification in human cell hybrids. Science. 1992;255:1425.
Uchida T, Sakakibara M, Imaizumi M, Abe T. Interaction of lung cancer cells and fibroblasts. Nippon Geka Gakkai Zasshi. 1991;92:592 (Abstract).
Umemura T, Hirata J, Kaneko S et al. Periodical appearance of erythropoietin-independent erythropoiesis in chronic myelogenous leukemia with cyclic oscillation. Acta Haematol. 1986;76:230.
Van den Akker J, Perot CH, Taillemite JL. Cytogénétique et leucémies aigües de l'enfant. Médecine Infantile. 1991;7:527.
Von Hoff DD, Needham-Vandevanter DR, Yucel J, Windle BE, Wahl GM. Amplified human Myc oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA. 1988;85:4804.
Weaver JD, Stetten G, Littlefield JW. Partial trisomies in two spontaneously arising long-lived human keratinocyte lines. In Vitro Cell Dev Biol. 1991;27A:670.
Wharton W. Newborn human skin fibroblasts senesce in vitro without acquiring adult growth factor requirements. Exp Cell Res. 1984;154:310.
Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989;9:3088.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolfrom, C., Raynaud, N., Maigne, J. et al. Periodic fluctuations in proliferation of SV-40 transformed human skin fibroblast lines with prolonged lifespan. Cell Biol Toxicol 10, 247–254 (1994). https://doi.org/10.1007/BF00756764
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00756764